397 related articles for article (PubMed ID: 23065704)
21. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; ; ; ; ; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
PLoS Genet; 2014 Feb; 10(2):e1004129. PubMed ID: 24550738
[TBL] [Abstract][Full Text] [Related]
22. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.
Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST
BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783
[TBL] [Abstract][Full Text] [Related]
23. Identification of Candidate mRNA Isoforms for Prostate Cancer-Risk SNPs Utilizing Iso-eQTL and sQTL Methods.
Moradi A; Sharma H; Sharma RD; Fernando A; Barrero RA; Batra J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293264
[TBL] [Abstract][Full Text] [Related]
24. An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.
DeRycke MS; Larson MC; Nair AA; McDonnell SK; French AJ; Tillmans LS; Riska SM; Baheti S; Fogarty ZC; Larson NB; O'Brien DR; Cheville JC; Wang L; Schaid DJ; Thibodeau SN
PLoS One; 2019; 14(4):e0214588. PubMed ID: 30958860
[TBL] [Abstract][Full Text] [Related]
25. Validation of a prostate cancer polygenic risk score.
Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
[TBL] [Abstract][Full Text] [Related]
26. Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.
Nurminen R; Rantapero T; Wong SC; Fischer D; Lehtonen R; Tammela TL; Nykter M; Visakorpi T; Wahlfors T; Schleutker J
Genes Chromosomes Cancer; 2016 Aug; 55(8):661-73. PubMed ID: 27113481
[TBL] [Abstract][Full Text] [Related]
27. MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.
Fischer D; Wahlfors T; Mattila H; Oja H; Tammela TL; Schleutker J
PLoS One; 2015; 10(5):e0127427. PubMed ID: 26020509
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
[TBL] [Abstract][Full Text] [Related]
29. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.
Teerlink CC; Thibodeau SN; McDonnell SK; Schaid DJ; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Fitzgerald LM; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Wahlfors T; Tammela T; Schleutker J; Wiklund F; Grönberg H; Emanuelsson M; Carpten J; Bailey-Wilson J; Whittemore AS; Oakley-Girvan I; Hsieh CL; Catalona WJ; Zheng SL; Jin G; Lu L; Xu J; ; Camp NJ; Cannon-Albright LA
Hum Genet; 2014 Mar; 133(3):347-56. PubMed ID: 24162621
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
Kar SP; Beesley J; Amin Al Olama A; Michailidou K; Tyrer J; Kote-Jarai Z; Lawrenson K; Lindstrom S; Ramus SJ; Thompson DJ; ; Kibel AS; Dansonka-Mieszkowska A; Michael A; Dieffenbach AK; Gentry-Maharaj A; Whittemore AS; Wolk A; Monteiro A; Peixoto A; Kierzek A; Cox A; Rudolph A; Gonzalez-Neira A; Wu AH; Lindblom A; Swerdlow A; ; ; Ziogas A; Ekici AB; Burwinkel B; Karlan BY; Nordestgaard BG; Blomqvist C; Phelan C; McLean C; Pearce CL; Vachon C; Cybulski C; Slavov C; Stegmaier C; Maier C; Ambrosone CB; Høgdall CK; Teerlink CC; Kang D; Tessier DC; Schaid DJ; Stram DO; Cramer DW; Neal DE; Eccles D; Flesch-Janys D; Edwards DR; Wokozorczyk D; Levine DA; Yannoukakos D; Sawyer EJ; Bandera EV; Poole EM; Goode EL; Khusnutdinova E; Høgdall E; Song F; Bruinsma F; Heitz F; Modugno F; Hamdy FC; Wiklund F; Giles GG; Olsson H; Wildiers H; Ulmer HU; Pandha H; Risch HA; Darabi H; Salvesen HB; Nevanlinna H; Gronberg H; Brenner H; Brauch H; Anton-Culver H; Song H; Lim HY; McNeish I; Campbell I; Vergote I; Gronwald J; Lubiński J; Stanford JL; Benítez J; Doherty JA; Permuth JB; Chang-Claude J; Donovan JL; Dennis J; Schildkraut JM; Schleutker J; Hopper JL; Kupryjanczyk J; Park JY; Figueroa J; Clements JA; Knight JA; Peto J; Cunningham JM; Pow-Sang J; Batra J; Czene K; Lu KH; Herkommer K; Khaw KT; ; Matsuo K; Muir K; Offitt K; Chen K; Moysich KB; Aittomäki K; Odunsi K; Kiemeney LA; Massuger LF; Fitzgerald LM; Cook LS; Cannon-Albright L; Hooning MJ; Pike MC; Bolla MK; Luedeke M; Teixeira MR; Goodman MT; Schmidt MK; Riggan M; Aly M; Rossing MA; Beckmann MW; Moisse M; Sanderson M; Southey MC; Jones M; Lush M; Hildebrandt MA; Hou MF; Schoemaker MJ; Garcia-Closas M; Bogdanova N; Rahman N; ; Le ND; Orr N; Wentzensen N; Pashayan N; Peterlongo P; Guénel P; Brennan P; Paulo P; Webb PM; Broberg P; Fasching PA; Devilee P; Wang Q; Cai Q; Li Q; Kaneva R; Butzow R; Kopperud RK; Schmutzler RK; Stephenson RA; MacInnis RJ; Hoover RN; Winqvist R; Ness R; Milne RL; Travis RC; Benlloch S; Olson SH; McDonnell SK; Tworoger SS; Maia S; Berndt S; Lee SC; Teo SH; Thibodeau SN; Bojesen SE; Gapstur SM; Kjær SK; Pejovic T; Tammela TL; ; ; Dörk T; Brüning T; Wahlfors T; Key TJ; Edwards TL; Menon U; Hamann U; Mitev V; Kosma VM; Setiawan VW; Kristensen V; Arndt V; Vogel W; Zheng W; Sieh W; Blot WJ; Kluzniak W; Shu XO; Gao YT; Schumacher F; Freedman ML; Berchuck A; Dunning AM; Simard J; Haiman CA; Spurdle A; Sellers TA; Hunter DJ; Henderson BE; Kraft P; Chanock SJ; Couch FJ; Hall P; Gayther SA; Easton DF; Chenevix-Trench G; Eeles R; Pharoah PD; Lambrechts D
Cancer Discov; 2016 Sep; 6(9):1052-67. PubMed ID: 27432226
[TBL] [Abstract][Full Text] [Related]
31. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.
Al Olama AA; Kote-Jarai Z; Berndt SI; Conti DV; Schumacher F; Han Y; Benlloch S; Hazelett DJ; Wang Z; Saunders E; Leongamornlert D; Lindstrom S; Jugurnauth-Little S; Dadaev T; Tymrakiewicz M; Stram DO; Rand K; Wan P; Stram A; Sheng X; Pooler LC; Park K; Xia L; Tyrer J; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Yeager M; Burdette L; Chung CC; Hutchinson A; Yu K; Goh C; Ahmed M; Govindasami K; Guy M; Tammela TL; Auvinen A; Wahlfors T; Schleutker J; Visakorpi T; Leinonen KA; Xu J; Aly M; Donovan J; Travis RC; Key TJ; Siddiq A; Canzian F; Khaw KT; Takahashi A; Kubo M; Pharoah P; Pashayan N; Weischer M; Nordestgaard BG; Nielsen SF; Klarskov P; Røder MA; Iversen P; Thibodeau SN; McDonnell SK; Schaid DJ; Stanford JL; Kolb S; Holt S; Knudsen B; Coll AH; Gapstur SM; Diver WR; Stevens VL; Maier C; Luedeke M; Herkommer K; Rinckleb AE; Strom SS; Pettaway C; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; Cannon-Albright L; Cybulski C; Wokołorczyk D; Kluźniak W; Park J; Sellers T; Lin HY; Isaacs WB; Partin AW; Brenner H; Dieffenbach AK; Stegmaier C; Chen C; Giovannucci EL; Ma J; Stampfer M; Penney KL; Mucci L; John EM; Ingles SA; Kittles RA; Murphy AB; Pandha H; Michael A; Kierzek AM; Blot W; Signorello LB; Zheng W; Albanes D; Virtamo J; Weinstein S; Nemesure B; Carpten J; Leske C; Wu SY; Hennis A; Kibel AS; Rybicki BA; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Zheng SL; Batra J; Clements J; Spurdle A; Teixeira MR; Paulo P; Maia S; Slavov C; Kaneva R; Mitev V; Witte JS; Casey G; Gillanders EM; Seminara D; Riboli E; Hamdy FC; Coetzee GA; Li Q; Freedman ML; Hunter DJ; Muir K; Gronberg H; Neal DE; Southey M; Giles GG; Severi G; ; ; ; ; Cook MB; Nakagawa H; Wiklund F; Kraft P; Chanock SJ; Henderson BE; Easton DF; Eeles RA; Haiman CA
Nat Genet; 2014 Oct; 46(10):1103-9. PubMed ID: 25217961
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.
Luedeke M; Rinckleb AE; FitzGerald LM; Geybels MS; Schleutker J; Eeles RA; Teixeira MR; Cannon-Albright L; Ostrander EA; Weikert S; Herkommer K; Wahlfors T; Visakorpi T; Leinonen KA; Tammela TLJ; Cooper CS; Kote-Jarai Z; Edwards S; Goh CL; McCarthy F; Parker C; Flohr P; Paulo P; Jerónimo C; Henrique R; Krause H; Wach S; Lieb V; Rau TT; Vogel W; Kuefer R; Hofer MD; Perner S; Rubin MA; Agarwal AM; Easton DF; Al Olama AA; Benlloch S; ; Hoegel J; Stanford JL; Maier C
Hum Mol Genet; 2016 Dec; 25(24):5490-5499. PubMed ID: 27798103
[TBL] [Abstract][Full Text] [Related]
33. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
Zhang P; Tillmans LS; Thibodeau SN; Wang L
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
[TBL] [Abstract][Full Text] [Related]
34. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
Gao P; Xia JH; Sipeky C; Dong XM; Zhang Q; Yang Y; Zhang P; Cruz SP; Zhang K; Zhu J; Lee HM; Suleman S; Giannareas N; Liu S; ; Tammela TLJ; Auvinen A; Wang X; Huang Q; Wang L; Manninen A; Vaarala MH; Wang L; Schleutker J; Wei GH
Cell; 2018 Jul; 174(3):576-589.e18. PubMed ID: 30033361
[TBL] [Abstract][Full Text] [Related]
35. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
Hoffmann TJ; Van Den Eeden SK; Sakoda LC; Jorgenson E; Habel LA; Graff RE; Passarelli MN; Cario CL; Emami NC; Chao CR; Ghai NR; Shan J; Ranatunga DK; Quesenberry CP; Aaronson D; Presti J; Wang Z; Berndt SI; Chanock SJ; McDonnell SK; French AJ; Schaid DJ; Thibodeau SN; Li Q; Freedman ML; Penney KL; Mucci LA; Haiman CA; Henderson BE; Seminara D; Kvale MN; Kwok PY; Schaefer C; Risch N; Witte JS
Cancer Discov; 2015 Aug; 5(8):878-91. PubMed ID: 26034056
[TBL] [Abstract][Full Text] [Related]
36. Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.
Mikropoulos C; Goh C; Leongamornlert D; Kote-Jarai Z; Eeles R
Future Oncol; 2014; 10(9):1679-94. PubMed ID: 25145435
[TBL] [Abstract][Full Text] [Related]
37. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
39. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
[TBL] [Abstract][Full Text] [Related]
40. Multiple newly identified loci associated with prostate cancer susceptibility.
Eeles RA; Kote-Jarai Z; Giles GG; Olama AA; Guy M; Jugurnauth SK; Mulholland S; Leongamornlert DA; Edwards SM; Morrison J; Field HI; Southey MC; Severi G; Donovan JL; Hamdy FC; Dearnaley DP; Muir KR; Smith C; Bagnato M; Ardern-Jones AT; Hall AL; O'Brien LT; Gehr-Swain BN; Wilkinson RA; Cox A; Lewis S; Brown PM; Jhavar SG; Tymrakiewicz M; Lophatananon A; Bryant SL; ; ; ; Horwich A; Huddart RA; Khoo VS; Parker CC; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Fisher C; Jamieson C; Cooper CS; English DR; Hopper JL; Neal DE; Easton DF
Nat Genet; 2008 Mar; 40(3):316-21. PubMed ID: 18264097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
